Glycopyrrolate Solution
Product Images NDC 59651-435

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 59651-435). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Glycopyrrolate Fig1)

This text displays Figure 1 showing the mean mDTS scores over time for Glycopyrrolate and Placebo. The scores are displayed at baseline, week 2, week 4, week 6, and week 8 with error bars indicating 2 standard errors.*

FDA Label Image

Fig2 (Glycopyrrolate Fig2)

This is a description of a medication identified as NDC 59651-435-47 Glycopyrrolate Oral Solution. It is intended for oral use only and each 5 mL contains Glycopyrrolate USP 1 mg. The product is distributed by Aurobindo Pharma USA, Inc. and comes in a 473 mL bottle. The usual dosage instructions can be found in the package insert. It is advised to keep the medication out of reach of children and store it at 20° to 25°C (68° to 77°F).*

FDA Label Image

Package Label-principal Display Panel (1 mg/5 mL (473 mL Carton Label))

This is a prescription medication called Glycopyrrolate Oral Solution with a concentration of 1 mg/5 mL. It is intended for oral use only and each 5 mL contains 1 mg of Glycopyrrolate USP. The typical dosage should be checked in the package insert for complete prescribing guidance. It should be stored at a temperature between 20° to 25°C. The product is distributed by Aurobindo Pharma USA, Inc. and manufactured in India.*

FDA Label Image

Str (Glycopyrrolate Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.